Viewing Study NCT00880360


Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2026-03-12 @ 1:55 PM
Study NCT ID: NCT00880360
Status: COMPLETED
Last Update Posted: 2018-03-27
First Post: 2009-04-10
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Trial of Intravenous Denileukin Diftitox in Stage III or IV Ovarian Cancer
Sponsor: The University of Texas Health Science Center at San Antonio
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Epithelial Ovarian Cancer View
None Extraovarian Peritoneal Cancer View
None Fallopian Tube Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Epithelial Ovarian Cancer View
None FIGO (International Fed of Gyn and Ob)Stage III or Stage … View
None Extraovarian Peritoneal Cancer View
None Fallopian Tube Carcinoma Failing View